J
John Hackett
Researcher at Abbott Laboratories
Publications - 87
Citations - 3693
John Hackett is an academic researcher from Abbott Laboratories. The author has contributed to research in topics: Viral load & Virus. The author has an hindex of 33, co-authored 84 publications receiving 3194 citations.
Papers
More filters
Journal ArticleDOI
A cloud-compatible bioinformatics pipeline for ultrarapid pathogen identification from next-generation sequencing of clinical samples
Samia N. Naccache,Scot Federman,Narayanan Veeraraghavan,Matei Zaharia,Deanna Lee,Erik Samayoa,Jerome Bouquet,Alexander L. Greninger,Ka Cheung Luk,Barryett Enge,Debra A. Wadford,Sharon Messenger,Gillian Genrich,Kristen Pellegrino,Gilda Grard,Eric M. Leroy,Bradley S. Schneider,Joseph N. Fair,Miguel Ángel Martínez,Pavel Isa,John A. Crump,Joseph L. DeRisi,Taylor Sittler,John Hackett,Steve Miller,Charles Y. Chiu +25 more
TL;DR: SURPI is described, a computational pipeline for pathogen identification from complex metagenomic NGS data generated from clinical samples, and use of the pipeline is demonstrated in the analysis of 237 clinical samples comprising more than 1.1 billion sequences.
Journal ArticleDOI
The Perils of Pathogen Discovery: Origin of a Novel Parvovirus-Like Hybrid Genome Traced to Nucleic Acid Extraction Spin Columns
Samia N. Naccache,Alexander L. Greninger,Deanna Lee,Lark L. Coffey,Tung Phan,Annie Rein-Weston,Andrew Aronsohn,John Hackett,Eric Delwart,Eric Delwart,Charles Y. Chiu +10 more
TL;DR: Analysis of environmental metagenome libraries detected PHV sequences in coastal marine waters of North America, suggesting that a potential association between PHV and diatoms (algae) that generate the silica matrix used in the spin columns may have resulted in inadvertent viral contamination during manufacture.
Journal ArticleDOI
A Metagenomic Analysis of Pandemic Influenza A (2009 H1N1) Infection in Patients from North America
Alexander L. Greninger,Eunice C. Chen,Taylor Sittler,Alex Scheinerman,Nareg Roubinian,Guixia Yu,Edward Y. Kim,Dylan R. Pillai,Cyril Guyard,Tony Mazzulli,Pavel Isa,Carlos F. Arias,John Hackett,Gerald Schochetman,Steve Miller,Patrick Tang,Charles Y. Chiu +16 more
TL;DR: Results indicate that a streamlined metagenomics detection strategy can potentially replace the multiple conventional diagnostic tests required to investigate an outbreak of a novel pathogen, and provide a blueprint for comprehensive diagnosis of unexplained acute illnesses or outbreaks in clinical and public health settings.
Journal ArticleDOI
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood.
Dianna Ng,Gregory M. Goldgof,Brian R. Shy,Andrew G. Levine,Joanna Balcerek,Sagar P. Bapat,John Prostko,Mary A. Rodgers,Kelly E. Coller,Sandra Pearce,Sergej Franz,Li Du,Mars Stone,Satish K. Pillai,Alicia Sotomayor-Gonzalez,Venice Servellita,Claudia Sanchez San Martin,Andrea Granados,Dustin R. Glasner,Lucy M. Han,Kent Truong,Naomi Akagi,David N. Nguyen,Neil M. Neumann,Daniel Qazi,Elaine Hsu,Wei Gu,Yale A. Santos,Brian Custer,Valerie Green,Phillip C. Williamson,Nancy K. Hills,Chuanyi M. Lu,Jeffrey D. Whitman,Susan L. Stramer,Candace Wang,Kevin Reyes,Jill Hakim,Kirk Sujishi,Fariba Alazzeh,Lori Pham,Edward Thornborrow,Ching Ying Oon,Steve Miller,Theodore W. Kurtz,Graham Simmons,John Hackett,Michael P. Busch,Charles Y. Chiu +48 more
TL;DR: There is evidence that seroreactivity using SARS-CoV-2 anti-nucleocapsid protein IgG and anti-spike IgM assays are generally predictive of in vitro neutralizing capacity, and the importance of using highly accurate tests for surveillance studies in low-prevalence populations is emphasized.
Journal ArticleDOI
Assessment of the Ability of a Fourth-Generation Immunoassay for Human Immunodeficiency Virus (HIV) Antibody and p24 Antigen To Detect both Acute and Recent HIV Infections in a High-Risk Setting
Mark Pandori,John Hackett,Brian Louie,Ana Vallari,Teri Dowling,Sally Liska,Jeffrey D. Klausner +6 more
TL;DR: This IA was found to be capable of detecting the majority (89%) of infections, including 80% of those considered acute infections based on the presence of HIV RNA and the lack of detectable antibody to HIV.